From: "Secretary, ACS Division of Chemical Health and Safety" <secretary**At_Symbol_Here**DCHAS.ORG>
Subject: [DCHAS-L] Pistoia webinar: CRISPR: what it is, and why it is having a profound impact on human health
Date: Tue, 18 Oct 2016 08:04:56 -0400
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
Message-ID: E2F6AD3E-9DFB-4852-BBD6-2255899B3153**At_Symbol_Here**

DCHAS members with biochemistry in their purview may find this of interest. CRISPR has the biosafety world in a tizzy...

- Ralph

From: Pistoia Alliance <comms**At_Symbol_Here**>
Subject: CRISPR: what it is, and why it is having a profound impact on human health: a Pistoia Alliance Debates webinar invitation
Date: October 18, 2016 at 8:00:14 AM EDT

Invitation to register for the Pistoia Alliance Debates webinar on CRISPR: what it is, and why it is having a profound impact on human health.
View this email in your browser

Pistoia Alliance Debates

CRISPR: what it is, and why it is having a profound impact on human health

Wednesday 16th November 2016 **At_Symbol_Here** 11am-midday EDT

Register for the CRISPR webinar

Scientific articles, science news, and even popular press stories have exploded on the topic of CRISPR and so it seems an appropriate time for us to delve in and get a better understanding of the technique itself, the applications and the implications.

  • We will commence with an elementary description of CRISPR, providing a general understanding of what it is and how it is carried out and, in particular, how certain proteins can cut DNA in precise, targeted locations
  • With that background, we will then move to the of the radical scientific implications, not least the acceleration of understanding of basic molecular biology that can be achieved by exploiting this technology
  • We will then explore contemporary bioinformatics principles and techniques and how they can evolve to support and indeed enhance the exploitation of CRISPR in science and Medicine
  • Next we will touch on the clinical potential of CRISPR, with special reference to the possibilities in the treatment of Cystic Fibrosis
  • And finally we will explore the ethics of CRISPR, and the importance of engaging and informing the public about this profound, revolutionary, scientific, technical and medical development.


  • Panel Chairman - Alvis Brazma - Senior Team Leader, Functional Genomics, EMBL-EBI
  • Biopharma Scientist perspective - Mike Ollman - Principal Scientist at Amgen
  • Clinical Perspective - Patrick Harrison, University College Cork

Register today for this free Pistoia Alliance Debates webinar on CRISPR, Wednesday 16th November 2016 **At_Symbol_Here** 11am-midday EDT.

Previous post   |  Top of Page   |   Next post

The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.